Abstract:Objective To evaluate the prognostic factors of invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas.Methods The retrospective case-control study was adopted.The clinical data of 110 patients who were confirmed as with IPMN of the pancreas by pathological examination at the Zhongshan Hospital of Fudan University from June 2005 to April 2014 were collected.Forty-one patients with invasive IPMN were screened for eligibility.Patients underwent chemotherapy according to the chemotherapy regimens of pancreatic ductal adenocarcinoma.The follow-up using outpatient examination and telephone interview was performed to detect the survival of patients by tumor markers,B-ultrasound and computed tomography (CT) once every half year up to February 2016.Analysis indicators included (1) follow-up situation:1-,3-,5-year survival rates,(2) prognostic factors:gender,age,tumor location,surgical procedures,tumor diameter,T stage,nerve invasion,lymph node invasion,heteromorphic resection margin,histopathological subtypes,pathological type of canceration,(3) stratified analysis:independent prognostic factors.The survival curve was drawn by the KaplanMeier method.Survival rate was calculated and univariate analysis was analyzed by the chi-square test.The multivariate analysis was done using the COX regression model,and survival analysis was done by the Log-rank test.Results (1) Follow-up:41 patients with invasive IPMN of the pancreas were followed up for 4.3-125.8months with a median follow-up time of 26.4 months,and median survival time and 1-,3-,5-year survival rates were respectively 32.8 months,90％,45％ and 39％.(2) Analysis of prognostic factors:the results of univariate analysis showed that nerve invasion and lymph node invasion were related factors affecting the prognosis of patients with invasive IPMN of the pancreas (x2 =5.996,11.552,P ＜ 0.05).The results of multivariate analysis showed that lymph node invasion was an independent risk factor affecting the poor prognosis of patients with invasive IPMN of the pancreas (HR =3.111,95％ confidence interval:1.271-7.614,P＜0.05).(3) The stratified analysis:a median survival time and 1-,3-,5-year survival rates were respectively 56.9 months,97％,57％,49％ in 29 patients with negative lymph nodes and 14.4 months,75％,15％,15％ in 12 patients with positive lymph nodes,with a statistically significant difference (x2 =11.552,P ＜ 0.05).Conclusion The histopathological subtypes and pathological type of canceration have limited prognostic value on invasive IPMN of the pancreas,however,the positive lymph nodes are an independent risk factor affecting the poor prognosis of patients with invasive IPMN of the pancreas.

The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm

Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI]

Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas with High-Grade Dysplasia and Associated Invasive Carcinoma

Lymphocyte-to-Monocyte Ratio Predicts Survival for Intraductal Papillary Mucinous Neoplasm with Associated Invasive Carcinoma of the Pancreas: Results from a High-Volume Center

[The Value of Preoperative CA19-9 Combined with Platelet-to-lymphocyte Ratio in Predicting Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms].

Circulating Cytokines Allow for Identification of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Preoperative predictors of malignancy and invasive carcinoma in intraductal papillary mucinous neoplasms

The Value of Systemic Inflammatory Markers in Identifying Malignancy in Mucinous Pancreatic Cystic Neoplasms

Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)

Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines

Prognostic Analysis of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas

Malignant Progression and Survival Analysis for Intraductal Papillary Mucinous Neoplasms Based on Risk Stratification

Intraductal Papillary Mucinous Neoplasms of the Pancreas--predictors of Malignancy.

Circulating Cytokine Model Allows for Identification of Malignant Intraductal Papillary Mucinous Neoplasms

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma

[Clinical Features and Prognosis of Intraductal Papillary Mucinous Neoplasms of Pancreas: Analysis of 38 Cases].

Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases

Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors

Validation of a Nomogram to Predict the Risk of Cancer in Patients with Intraductal Papillary Mucinous Neoplasm and Main Duct Dilatation of 10 Mm or Less

Prognostic Value of Histological Subtype in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Retrospective Analysis of Outcome from One Single Center.

External Validation of a Nomogram to Predict Malignancy Risk in Patients with Intraductal Papillary Mucinous Neoplasms, Using Eastern and Western Cohorts